Extended-spectrum β-lactamases:: Epidemiology, detection, and treatment

被引:92
|
作者
Nathisuwan, S
Burgess, DS
Lewis, JS
机构
[1] Univ Texas, Hlth Sci Ctr, Clin Pharm Programs, Dept Pharmacol,MSC 6220, San Antonio, TX 78229 USA
[2] Univ Texas, Coll Pharm, Austin, TX 78712 USA
来源
PHARMACOTHERAPY | 2001年 / 21卷 / 08期
关键词
D O I
10.1592/phco.21.11.920.34529
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Extended-spectrum P-lactamases (ESBLs) are extremely broad spectrum P-lactamase enzymes found in a variety of Enterobacteriaceae. Most strains producing these P-lactamases are Klebsiella pneumoniae, other Klebsiella species (i.e., K. oxytoca), and Escherichia coli. When producing these enzymes, organisms become highly effective at inactivating various P-lactam antibiotics. In addition, ESBL-producing bacteria are frequently resistant to many classes of antibiotics, resulting in difficult-to-treat infections. Other problems due to ESBL-producing bacteria are difficulty in detecting the presence of ESBLs, limited treatment options, and deleterious impact on clinical outcomes. Clinicians should be familiar with the clinical significance of these enzymes and potential strategies for dealing with this growing problem.
引用
收藏
页码:920 / 928
页数:9
相关论文
共 50 条